SASH1 and head and neck squamous cell carcinoma: By systematically integrating multi-platform transcriptomics, machine learning, and multi-dimensional validation, this study identifies SASH1 as a robust prognostic biomarker and a potential predictor of therapeutic response in HNSCC.